Hospital at Home programs: Decentralized inpatient care but centralized laboratory testing?

•Explore different models of Hospital at Home programs.•Emphasize the crucial roles of clinical laboratories in bolstering Hospital at Home initiatives.•Focus on two key quality requirements for laboratory testing in Hospital at Home programs: sample integrity and turnaround times.•Discuss opportuni...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical biochemistry 2024-07, Vol.129, p.110779, Article 110779
Hauptverfasser: Shi, Junyan, Yu-Wei Chen, Roy, Wang, Li
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Explore different models of Hospital at Home programs.•Emphasize the crucial roles of clinical laboratories in bolstering Hospital at Home initiatives.•Focus on two key quality requirements for laboratory testing in Hospital at Home programs: sample integrity and turnaround times.•Discuss opportunities and barriers for maximizing laboratory support in Hospital at Home programs. The Hospital at Home (HaH) program has experienced accelerated growth in major Canadian provinces, driven in part by technological advancements and evolving patient needs during the COVID-19 pandemic. As an increasing number of hospitals pilot or implement these innovative programs, substantial resources have been allocated to support clinical teams. However, it is crucial to note that the vital roles played by clinical laboratories remain insufficiently acknowledged. This mini review aims to shed light on the diverse functions of clinical laboratories, spanning the preanalytical, analytical, and post-analytical phases within the HaH program context. Additionally, the review will explore recent advancements in clinical testing and the potential benefits of integrating new technologies into the HaH framework. Emphasizing the integral role of clinical laboratories, the discussion will address the current barriers hindering their active involvement, accompanied by proposed solutions. The capacity and efficiency of the HaH program hinge on sustained collaborative efforts from various teams, with clinical laboratories as crucial team players. Recognizing and addressing the specific challenges faced by clinical laboratories is essential for optimizing the overall performance and impact of the HaH initiative.
ISSN:0009-9120
1873-2933
1873-2933
DOI:10.1016/j.clinbiochem.2024.110779